イマイ カズオ
IMAI Kazuo
今井 一男 所属 埼玉医科大学 医学部 臨床検査医学(中央検査部) 職種 専任講師 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019. |
掲載誌名 | 正式名:Journal of diabetes investigation |
著者・共著者 | Shinnosuke Yanagisawa,Yoichi Oikawa,Sotaro Takagi,Yuta Horikoshi,Atsushi Satomura,Kazuo Imai,Jun Sakai,Noriomi Ishibashi,Norihito Tarumoto,Shinichiro Iida,Hideto Nakayama,Yoshiyuki Haga,Shigefumi Maesaki,Akira Shimada |
発行年月 | 2021/12 |
概要 | INTRODUCTION: Many clinical studies have identified significant predictors or risk factors for the severity or mortality of coronavirus disease 2019 (COVID-19) cases. However, there are very limited reports on the risk factors for requiring oxygen therapy during hospitalization. In particular, we sought to investigate whether plasma glucose and HbA1c levels could be risk factors for oxygen therapy requirement. MATERIALS AND METHODS: A single-center, retrospective study was conducted of 131 COVID-19 patients hospitalized at Saitama Medical University Hospital between March 2020 and November 2020. To identify the risk factors for oxygen therapy requirement during hospitalization, a stepwise multivariate binary logistic regression analysis was performed using several clinical parameters commonly obtained on admission, including plasma glucose and HbA1c levels. RESULTS: Of the 131 patients with COVID-19, 33.6% (44/131) received oxygen therapy during hospitalization. According to the logistic regression analysis, male sex (odds ratio [OR]: 8.76, 95% confidence interval [CI]: 1.65-46.5, P < 0.05), age (OR: 1.07, 95% CI: 1.02-1.12, P < 0.01), HbA1c levels (OR: 1.94, 95% CI: 1.09-3 |
DOI | 10.1111/jdi.13743 |
PMID | 34958706 |